Premium
Simultaneous assays of cancer‐associated antigens in various neoplastic disorders
Author(s) -
Franchimont P.,
Zangerle P. F.,
Nogarede J.,
Bury J.,
Molter F.,
Reuter A.,
Hendrick J. C.,
Collette J.
Publication year - 1976
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197612)38:6<2287::aid-cncr2820380616>3.0.co;2-2
Subject(s) - carcinoembryonic antigen , medicine , antigen , radioimmunoassay , population , cancer , breast cancer , stage (stratigraphy) , radiation therapy , carcinoma , chemotherapy , pathology , gastroenterology , oncology , immunology , biology , paleontology , environmental health
Five tumor markers were measured simultaneously in serum by radioimmunoassay: carcinoembryonic antigen (CEA), alpha‐fetoprotein (AFP), human chorionic gonadotropin (HCG), the β subunit of HCG, and Kappa casein. In a population of 935 normal subjects these antigens were undetectable or found within precise limits. In patients with tumors of various origins the rate of pathologically elevated levels was 72% at the beginning of the clinical course (194 cases). This high rate was primarily due to the simultaneous measurement of CEA, βHCG, and casein. AFP was of little importance. The simultaneous measurement of these tumor markers may be one biochemical element of diagnosis of carcinoma, although this criterion is neither absolute nor specific, as 14.7% of patients with non‐neoplastic disorders (234 cases) were positive for one antigen. In the presence of metastases (112 cases) the rate of pathologic levels of at least one antigen was increased: 86% due to CEA and casein assay at the same time as their absolute levels were increased. Surgical removal reduces the rate of positivity of these antigens to 37%. As was shown in patients with breast cancer, the rate was 10% when the tumor had been removed at Stage N − and 54% when it was removed at Stage N + . Thus, the persistence of pathologic levels could be correlated with the capacity for recurrence or metastases. Finally chemotherapy, radiotherapy, or both, do not decrease the rate of positivity of the tumor markers.